Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deep learning-based H&E-derived risk scores in colorectal cancer: associations with tumour morphology, biology, and predicted drug response.
Reitsam NG, Jiang X, Liang J, Grosser B, Grozdanov V, Loeffler CM, Gustav M, Lenz T, Muti HS, Carrero ZI, West NP, Quirke P, Foersch S, Jesinghaus M, Müller W, Yuan T, Hoffmeister M, Brenner H, Jonnagaddala J, Hawkins NJ, Ward RL, Grabsch HI, Märkl B, Kather JN. Reitsam NG, et al. Among authors: ward rl. J Pathol. 2026 Feb 20. doi: 10.1002/path.70039. Online ahead of print. J Pathol. 2026. PMID: 41716034
Artificial intelligence-based tumor-stroma ratio quantification reveals prognostic value and stromal-driven immunosuppression in colorectal cancer: an international validation study.
Ye H, Zhao K, Cui Y, Li Z, Zhang H, Zhong ME, Fan C, Huang H, Hawkins NJ, Ward RL, Sun XF, Song J, Liu Z, Jonnagaddala J, Tong T, Yao S. Ye H, et al. Among authors: ward rl. J Transl Med. 2026 Jan 24;24(1):269. doi: 10.1186/s12967-026-07681-6. J Transl Med. 2026. PMID: 41580788 Free PMC article.
Pilot testing of the Research Impact Assessment Framework.
Ward RL, Nutbeam D, Mijnhardt W, Nelson P, Todd AL, Richards J, Jackson K, Khan NN, Chung S. Ward RL, et al. Aust Health Rev. 2025 Dec 4;49(6):AH25214. doi: 10.1071/AH25214. Aust Health Rev. 2025. PMID: 41082917
A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function.
Sandhu G, Gordon EA, Adattini J, O'Neill N, Chambers P, Johnson DW, Kelly A, Liauw W, Mallett AJ, Michael M, Mirkov S, Scuderi C, Shingleton J, Siderov J, Sprangers B, Stein BN, Tunnicliffe DJ, Ward RL; ADDIKD Working Group. Sandhu G, et al. Among authors: ward rl. EClinicalMedicine. 2025 Mar 25;82:103101. doi: 10.1016/j.eclinm.2025.103101. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40290846 Free PMC article. Review.
Aligning kidney function assessment in patients with cancer to global practices in internal medicine.
Sandhu G, Adattini J, Gordon EA, O'Neill N, Bagnis C, Chambers P, Martin JH, Flynn A, Ibrahim K, Jardine MJ, Johnson DW, Jones GRD, Karapetis CS, Kelly A, Kichenadasse G, Kliman DS, Liauw W, Lucas C, Mallett AJ, Malyszko J, Michael M, Pollock CA, Roberts DM, Rosner MH, Routledge DJM, Scuderi C, Shingleton J, Shortt J, Siderov J, Sprangers B, Stein BN, Tunnicliffe DJ, Webber K, Ward RL; ADDIKD Working Group. Sandhu G, et al. Among authors: ward rl. EClinicalMedicine. 2025 Mar 25;82:103102. doi: 10.1016/j.eclinm.2025.103102. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40290845 Free PMC article. Review.
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.
Sandhu G, Adattini J, Armstrong Gordon E, O'Neill N, Bagnis C, Boddy AV, Chambers P, Flynn A, Hamilton B, Ibrahim K, Johnson DW, Karapetis C, Kelly A, Kerr KA, Kichenadasse G, Kliman DS, Kurkard C, Liauw W, Lucas C, Mallett AJ, Malyszko J, McCaughan G, Michael M, Mirkov S, Morris E, Pollock CA, Roberts DM, Routledge DJ, Scuderi C, Shingleton J, Shortt J, Siderov J, Sprangers B, Stein BN, Tey A, Webber K, Wichart J, Wong R, Ward RL; ADDIKD Working Group. Sandhu G, et al. Among authors: ward rl. EClinicalMedicine. 2025 Mar 25;82:103161. doi: 10.1016/j.eclinm.2025.103161. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40290844 Free PMC article. Review.
Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors.
Nasca V, Zhao J, Ros J, Lonardi S, Zwart K, Cohen R, Fakih M, Jayachandran P, Roodhart JML, Derksen J, Intini R, Bergamo F, Mazzoli G, Ghelardi F, Ligero M, Jonnagaddala J, Hawkins N, Ward RL, Wankhede D, Brenner H, Hoffmeister M, Vitellaro M, Salvatore L, Gallois C, Laurent-Puig P, Cremolini C, Overman MJ, Taieb J, Tougeron D, Andre T, Kather JN, Sundar R, Carmona J, Elez E, Koopman M, Pietrantonio F. Nasca V, et al. Among authors: ward rl. J Immunother Cancer. 2025 Feb 10;13(2):e010598. doi: 10.1136/jitc-2024-010598. J Immunother Cancer. 2025. PMID: 39929672 Free PMC article.
497 results